CV Sciences (CVSI) FCF Margin Growth (1y) (2014 - 2026)
CV Sciences (CVSI) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -614.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -614.00 |
| Mar 31, 2026 | 642.00 |
| Dec 31, 2025 | -466.00 |
| Sep 30, 2025 | -658.00 |
| Jun 30, 2025 | 802.00 |
| Mar 31, 2025 | 959.00 |
| Dec 31, 2024 | -169.00 |
| Sep 30, 2024 | -269.00 |
| Jun 30, 2024 | -3,702.00 |
| Mar 31, 2024 | -3,645.00 |
| Dec 31, 2023 | -843.00 |
| Sep 30, 2023 | 1,412.00 |
| Jun 30, 2023 | 6,383.00 |
| Mar 31, 2023 | 3,203.00 |
| Dec 31, 2022 | 2,885.00 |
| Sep 30, 2022 | 1,612.00 |
| Jun 30, 2022 | 3,150.00 |
| Mar 31, 2022 | 2,707.00 |
| Dec 31, 2021 | 2,054.00 |
| Sep 30, 2021 | -444.00 |